Now comes the beauty of the "Platform"...if it can be that successful for HSV, why not successful for other viruses?How many viruses currently affect human health in a big way?
It's a very long list...
Even if the viruses have a vaccine, in some cases it does not give 100% protection and the CPP may enhance the effectiveness.
Early days yet and just guessing.
Ann: In vivo success - peptide vaccine in Herpes Simplex Virus, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.070(5.56%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.19 | $88.49K | 72.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2057 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 2694 | 3 |
View Market Depth
| Last trade - 10.25am 29/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |